STAT

OCTOBER 13, 2024

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person familiar with the situation and employee posts on social media. It is the latest in a series of retrenchments by high-profile gene-editing companies. A spokesperson for SalioGen declined to comment.

141

141

Drug Topics

OCTOBER 13, 2024

In case you missed it, this week we had stories about medication-related disaster preparedness, COVID-19 and cardiovascular risks, legal battles over inflated insulin prices, and more.

98

98

pharmaphorum

OCTOBER 13, 2024

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year.Marstacimab will be launched as Hympavzi to treat haemophilia A without factor VIII inhibitors and haemophilia B without factor IX inhibitors in patients aged 12 and older and is the first drug in the anti-TFPI class to be approved in the US.

FDA 111

FDA 111

The FDA Law Blog

OCTOBER 13, 2024

By Mark A. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit of a tumultuous history in its 12 short years of existence. Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.

Documentation 64

Documentation FDA 64

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Mission-Driven Marketing Blog

OCTOBER 13, 2024

Imagine your nonprofit’s donor database is suddenly lost, sensitive information exposed, website taken down, all because of a single click or missed update. For nonprofits, cybersecurity isn’t just about protecting data; it’s about safeguarding the trust your supporters place in you and ensuring the you can continue your mission.

52

52

The Honest Apothecary

OCTOBER 13, 2024

Readers of The Honest Apothecary Re-Imagined are coming to learn that this blog has now become the home for short articles and thoughts on a wide variety of topics, well beyond the walls of the pharmacy. I still love medicine. But I needed a home for all the things I care deeply about. In that […] The post A Story in Five Colors – and simplify, simplify!

52

52

Med Ed 101

OCTOBER 13, 2024

The American Thyroid Association defines hypothyroidism as a result of an “underactive thyroid gland.” Common symptoms include fatigue, cold sensitivity, dry skin, weight gain, hair loss, high cholesterol, or constipation. The recommended treatment is replacing the body with T4 (levothyroxine). Currently, the guidelines recommend one standard treatment, but there are other options available.

52

52